Literature DB >> 20527998

Escitalopram in the treatment of major depressive disorder in adolescent patients. Profile report.

Lily P H Yang1, Lesley J Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20527998     DOI: 10.2165/11204690-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  13 in total

Review 1.  Escitalopram: in the treatment of major depressive disorder in adolescent patients.

Authors:  Lily P H Yang; Lesley J Scott
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

Review 2.  Escitalopram: a review of its use in the management of major depressive disorder.

Authors:  David Murdoch; Susan J Keam
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Efficacy of antidepressants in juvenile depression: meta-analysis.

Authors:  Evangelia M Tsapakis; Federico Soldani; Leonardo Tondo; Ross J Baldessarini
Journal:  Br J Psychiatry       Date:  2008-07       Impact factor: 9.319

4.  A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

Authors:  Karen Dineen Wagner; Jeffrey Jonas; Robert L Findling; Daniel Ventura; Khalil Saikali
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-03       Impact factor: 8.829

Review 5.  Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management.

Authors:  Amy H Cheung; Rachel A Zuckerbrot; Peter S Jensen; Kareem Ghalib; Danielle Laraque; Ruth E K Stein
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

6.  Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.

Authors:  Boris Birmaher; David Brent; William Bernet; Oscar Bukstein; Heather Walter; R Scott Benson; Allan Chrisman; Tiffany Farchione; Laurence Greenhill; John Hamilton; Helene Keable; Joan Kinlan; Ulrich Schoettle; Saundra Stock; Kristin Kroeger Ptakowski; Jennifer Medicus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-11       Impact factor: 8.829

Review 7.  Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

Authors:  S Hetrick; S Merry; J McKenzie; P Sindahl; M Proctor
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

8.  Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.

Authors:  Graham J Emslie; Daniel Ventura; Andrew Korotzer; Stavros Tourkodimitris
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-07       Impact factor: 8.829

Review 9.  Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

Authors:  Marc Stone; Thomas Laughren; M Lisa Jones; Mark Levenson; P Chris Holland; Alice Hughes; Tarek A Hammad; Robert Temple; George Rochester
Journal:  BMJ       Date:  2009-08-11

Review 10.  Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.

Authors:  David Cohen; Emmanuelle Deniau; Alejandro Maturana; Marie-Laure Tanguy; Nicolas Bodeau; Réal Labelle; Jean-Jacques Breton; Jean-Marc Guile
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.